01/01/1992 - "A sensitive and specific radioimmunoassay for a new anti-ulcer drug TG-51 has been developed and applied to the evaluation of its pharmacokinetics in humans. "
01/01/1992 - "Development of radioimmunoassay for TG-51, a new anti-ulcer drug, and its application."
11/01/1987 - "In conclusion, TEI-5103, when given orally, distributes in the gastric mucosa as a target issue directly from the lumen; and only the oral and gastric route of administration lead to the anti-ulcer effect."
11/01/1987 - "These results suggest that the presence of TEI-5103 in the stomach is necessary to elicit its anti-ulcer effect. "
11/01/1987 - "The results indicate that TEI-5103 increases GMBF by acting directly on the gastric microcirculation and that this increasing effect may contribute to the anti-ulcer activity of TEI-5103."
|2.||Peptic Ulcer (Peptic Ulcers)
|1.||Acetic Acid (Vinegar)
|2.||Serotonin (5 Hydroxytryptamine)
|4.||propionic acid (potassium propionate)